Justin Zelin
Stock Analyst at BTIG
(2.15)
# 1,545
Out of 4,667 analysts
35
Total ratings
20.69%
Success rate
5.18%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Justin Zelin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Maintains: Buy | $55 → $62 | $25.75 | +140.78% | 2 | Jul 9, 2024 | |
| JSPR Jasper Therapeutics | Initiates: Buy | $90 | $21.47 | +319.19% | 1 | Jul 8, 2024 | |
| TCRX TScan Therapeutics | Initiates: Buy | $12 | $3.99 | +200.75% | 1 | May 16, 2024 | |
| LYRA Lyra Therapeutics | Downgrades: Neutral | n/a | $0.18 | - | 2 | May 6, 2024 | |
| CARM Carisma Therapeutics | Initiates: Buy | $6 | $0.83 | +618.74% | 1 | Apr 11, 2024 | |
| VKTX Viking Therapeutics | Maintains: Buy | $100 → $125 | $52.50 | +138.10% | 4 | Mar 26, 2024 | |
| VSTM Verastem | Assumes: Buy | $27 | $3.79 | +612.40% | 1 | Nov 21, 2023 | |
| MBIO Mustang Bio | Maintains: Buy | $20 → $16 | $0.21 | +7,551.84% | 4 | Aug 15, 2023 | |
| IMCR Immunocore Holdings | Maintains: Buy | $85 → $91 | $31.99 | +184.46% | 2 | Aug 11, 2023 | |
| ACET Adicet Bio | Maintains: Buy | $20 → $10 | $0.94 | +961.91% | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.71 | +838.42% | 1 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $37 | $7.97 | +364.24% | 2 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $35 | $15.36 | +127.86% | 1 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $39.89 | +125.65% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $31 | $9.96 | +211.40% | 1 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $16 | $102.09 | -84.82% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.77 | - | 3 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $10 | $5.32 | +87.97% | 3 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $2.70 | +1,381.48% | 1 | May 18, 2021 |
IDEAYA Biosciences
Jul 9, 2024
Maintains: Buy
Price Target: $55 → $62
Current: $25.75
Upside: +140.78%
Jasper Therapeutics
Jul 8, 2024
Initiates: Buy
Price Target: $90
Current: $21.47
Upside: +319.19%
TScan Therapeutics
May 16, 2024
Initiates: Buy
Price Target: $12
Current: $3.99
Upside: +200.75%
Lyra Therapeutics
May 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.18
Upside: -
Carisma Therapeutics
Apr 11, 2024
Initiates: Buy
Price Target: $6
Current: $0.83
Upside: +618.74%
Viking Therapeutics
Mar 26, 2024
Maintains: Buy
Price Target: $100 → $125
Current: $52.50
Upside: +138.10%
Verastem
Nov 21, 2023
Assumes: Buy
Price Target: $27
Current: $3.79
Upside: +612.40%
Mustang Bio
Aug 15, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $0.21
Upside: +7,551.84%
Immunocore Holdings
Aug 11, 2023
Maintains: Buy
Price Target: $85 → $91
Current: $31.99
Upside: +184.46%
Adicet Bio
Aug 10, 2023
Maintains: Buy
Price Target: $20 → $10
Current: $0.94
Upside: +961.91%
Jul 25, 2023
Initiates: Buy
Price Target: $16
Current: $1.71
Upside: +838.42%
Jul 3, 2023
Maintains: Buy
Price Target: $30 → $37
Current: $7.97
Upside: +364.24%
Jun 26, 2023
Maintains: Buy
Price Target: $34 → $35
Current: $15.36
Upside: +127.86%
Jun 13, 2023
Maintains: Buy
Price Target: $85 → $90
Current: $39.89
Upside: +125.65%
May 17, 2023
Initiates: Buy
Price Target: $31
Current: $9.96
Upside: +211.40%
Mar 28, 2023
Maintains: Buy
Price Target: $10 → $16
Current: $102.09
Upside: -84.82%
Dec 6, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.77
Upside: -
Nov 16, 2022
Maintains: Buy
Price Target: $21 → $10
Current: $5.32
Upside: +87.97%
May 18, 2021
Initiates: Buy
Price Target: $40
Current: $2.70
Upside: +1,381.48%